Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Geriatric Medicine
Lipid Disorders
Questions discussed in this category
Would you consider transitioning patients older than 75 years of age with coronary disease from statins and/or other lipid-lowering agents to PCSK9 inhibitors given concerns for polypharmacy, provided their LDL levels remain at or below goal?
2 Answers available
26307
Related Topics in Geriatric Medicine
General Primary Care
General Internal Medicine
Primary Care
General Geriatric Medicine
Rheumatology
Neurology
Endocrinology
Dementia
Cardiology
General Hospital Medicine